Navigation Links
Surgeons Perform Robotic Gastric Bypass Surgery

Researchers from Stanford School of Medicine had used remote controlled robotic arms and a binocular camera to perform laproscopic gastric bypass surgery successfully. Their research findings are published // in the August issue of Archives of Surgery.

The laproscopic gastric bypass surgery (a Roux-en-Y procedure) is often considered the most challenging minimally invasive procedure in general surgery. Although robotic surgical techniques have been developed to assist laproscopic gastric bypass surgery, the complex geometry of the surgery has required repositioning of the robot, complicating its use.

Researchers fro the findings reported that the first 10 patients to undergo a totally robotic laproscopic Roux-en-Y gastric bypass surgery (during March and April 2004) using a technique developed to minimize robot repositioning. The results were compared with a sample of 10 patients who had undergone standard laproscopic Roux-en-Y gastric bypass surgery during July to September 2002. There were no significant differences in the general health, age or body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) of the two sets of patients. All patients were women. The researchers compared surgical times as well as the ratio of the procedure time to the patient’s BMI.

The number and severity of complication were comparable, the researchers found. The rate at which the operative times improved indicate that the learning curve for the robotic procedure is considerably shorter. We found that the mean minutes per BMI of our second five robotic procedures was 3.45 minutes, whereas the laproscopic data for our senior attending surgeon did not attain a comparable five-case mean of the metric until case 42.

Reluctance to use new technology such as the surgical robot often reflects surgeon concern over increasing complication rates, increased operative times, and steep learning curves, the author
'"/>




Page: 1 2

Related medicine news :

1. Surgeons implant second artificial heart
2. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
3. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
4. Surgeons Not Happy With Treatment Offered To Their Patients
5. Surgeons being paid triple the amount to cut waiting lists
6. Govt Hospital Surgeons Perform A Rare Cardiac Surgery
7. Virtual Reality Simulation Could Help In Training Surgeons
8. Plastic Surgeons Looking Forward To First Full Face Transplant
9. Cash-Strapped Hospital loses Top Surgeons
10. Surgery Simulators Offer Better Surgeons And Safer Surgeries
11. Surgeons Retrieve ‘Three-Year-Old’ Forceps From Patient’s Abdoen
Post Your Comments:
(Date:7/9/2008)...aleate (Acepromazine) is on extended backorder fro...nd this preparation into Gourmeds™ (chewable...nsion in the most frequently prescribed strengths....r veterinary use only. , ... -- Commonly prescribed for both cats and dogs, A...
(Date:7/9/2008)...he Maltese healthcare system,will be the focus of ... the,world learn how the island nation,s healthcar...odel for the European Union to follow. Affiliated,...um to discuss the future,of healthcare and informa...tions., Four recognized experts in healthcare and...
(Date:7/9/2008)...mpany Provides Interoperable EHR Solution Capa...ROLLTON, Ga., July 9 /PRNewswire/ -- Greenway Medi...e National Health IT Week,s Capitol Hill,Technolog...ne 9, 2008. The,showcase marked one of the healthc...ime demonstrations of ambulatory software provider...
(Date:7/9/2008)...r Summer, LAUREL, Miss., July 9 /PRNewswire/ -- W...popular parking place for TV-watchers, Sanderson F...mer program to encourage,families to get healthy b..., Studies show that over the course of a year, ch... school or participating in any activity other,tha...
Breaking Medicine News(10 mins):Health News: Wedgewood Pharmacy Responds to Acepromazine Maleate Drug Shortage 2Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 2Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 3Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 2Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 3Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 4Health News:Sanderson Farms Launches New Summer Program Encouraging Families to Get Healthy 2
...creased by 12% in six years, according to the char...are now diagnosed with the disease, 3,000 of those...elanomas in men is that they tend to occur more co...they are often on the lower leg and more noticeabl...
...nancy can increase a mother's risk of having a hyp...ere very anxious// in the last three months of pre.... Lead researcher Professor Vivette Glover, of Im... only applied to women who had extreme anxiety, an...
...n somebody is likely to have an epileptic seizure....enly and without warning and can lead to disabilit... la Pitie-Salpetriere, Paris, believe it may be po...res by carrying out an electroencephalogram (EEG)....
...than 100 years. And while most of the popular reme... the use of aspirin has increased. This powerful p...nt blood clots, and even reduce the risk of heart ...35 years since aspirin's potent anti-clotting effe...
Other Medicine News:
(Date:7/8/2008)...- McGraw-Hill Professional, a leading,global provi...d medical,communities, today announced the additio...its comprehensive online pharmacy education,resour... ). Through an alliance with,Doctor Evidence, deve...ical,studies, AccessPharmacy now provides in-conte...
(Date:7/7/2008)... Includes ANA598 and ANA773 Acting via In... Conference Call Today at 2:00 PM... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ann...ation of the Toll-Like Receptor-7 (TLR7) mechanism...n preclinical pharmacology testing,and the results...
(Date:7/7/2008)...-- OrbusNeich today announced that data,presented ...e Society of,Interventional Cardiology demonstrate... outcomes when compared to drug-eluting stents., ...principal,investigator and a professor with the Fe...ology, Department of Clinical Medicine and Cardiov...
(Date:7/6/2008)...ing Authorization Application currently ...uly 7 /- Cell Therapeutics,...the publication of results from its,randomized pha...glumex,CT-2103) with gemcitabine or vinorelbine f...tients with previously untreated non-small cell,lu...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5APIC launches first national C difficile prevalence study 14826 1APIC launches first national C difficile prevalence study 14826 2Cato Study Finds Iran a Surprising Model for Kidney Markets 14823 1Cato Study Finds Iran a Surprising Model for Kidney Markets 14823 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 1573 1NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 1573 2Subterfuge counter surveillance and assassination 3A The bodys fight with cervical cancer 2560 1Subterfuge counter surveillance and assassination 3A The bodys fight with cervical cancer 2560 2
...BOULDER, Colo.--(BUSINESS WIRE)--Jul 5, 2007 - Arr...hat its Chief Executive Officer,Robert E. Conway,...rowth Conference on July 10 in New York City. The ... through a webcast on the,Array BioPharma website....ng Growth Conference,Presenter: Robert E. Co...
... REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, ...nomics Ltd , a leading microRNA,company, announced...esident, will present at CE Unterberg, Towbin Emer...uly 10, at 11:00 am EST at,the Mandarin Oriental H...esentation will be available on,the "Investors" se...
Other Medicine Technology:Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI.
Used to provide bladder drainage by percutaneous placement of a Malecot catheter. Supplied sterile in peel-open packages. Intended for one-time use.
Surgisis ES is designed to provide enhanced strength for intraoperative applications. Supplied sterile in peel-open packages. Intended for single patient, one-time use.
Stratasis Urethral Sling is intended for implantation to reinforce soft tissues where weakness exists. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: